International application published with international search report
WO2019174617A1 - Anti-claudin 18.2 antibodies - Google Patents
Antibodies, Free Full-Text
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy, Biomarker Research
Frontiers New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
WO2022063272A1 - Novel anti-claudin18 antibodies - Google Patents
US20220041712A1 - Anti-claudin 18 antibodies and methods of use thereof - Google Patents
WO2021032157A1 - Novel anti-cldn18.2 antibodies - Google Patents
Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications - ScienceDirect
Cancers, Free Full-Text
Cancers, Free Full-Text